Drug Trial Radar · NCT06504446
Study to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults With Refractory or Unexplained Chronic Cough
Last checked: Nov 19, 2026Latest source record: Jun 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
455
Planned (sponsor's estimate)
Start
Sep 24, 2024
Primary completion
Jun 15, 2026
Study completion Jun 29, 2026
Sponsor
- Lead sponsor
- Nocion TherapeuticsIndustry
- Sponsor type
- Industry
- Collaborators
- IQVIA Pty Ltd
- First posted
- Jul 16, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a phase 2b, randomized, double-blind, placebo-controlled study investigating the efficacy, safety, and tolerability of Taplucainium Inhalation Powder (NOC-110) once daily in adults with refractory or unexplained chronic cough.
Conditions
- Refractory or Unexplained Chronic Cough
Interventions
NOC-110Drug
Inhalation powder
PlaceboOther
Inhalation powder
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in 24-hour Coughs per hour from BaselineTime frame: Baseline to End of Treatment
Locations
106 sites in 6 countries. Site status is shown where the registry gives one.
G & L Research, LLC
Foley, Alabama
Medical Research of Arizona
Scottsdale, Arizona
AMR Phoenix
Tempe, Arizona
Little Rock Allergy & Asthma, P.A. Clinical Research Center
Little Rock, Arkansas
So Cal Clinical Research
Huntington Beach, California
Allergy and Asthma Associates of Southern California dba Southern California Research
Laguna Niguel, California
Paradigm Clinical Research Centers, LLC - Modesto
Modesto, California
NewportNativeMD,Inc
Newport Beach, California
Center for Clinical Trials, LLC
Paramount, California
Paradigm Clinical Research Centers, LLC
Redding, California
DaVinci Research LLC.
Roseville, California
Allergy & Asthma Associates of Santa Clara Valley
San Jose, California
California Allergy & Asthma Medical Group Inc.
San Jose, California
Allergy, Asthma, and Immunology Medical Group
Ventura, California
Allergy and Asthma Clinical Research Inc
Walnut Creek, California
Lynn Institute of Denver
Aurora, Colorado
Innovative Research of West Florida, Inc.
Clearwater, Florida
Omega Research Debary, LLC
DeBary, Florida
Jacksonville Center for Clinical Research
Jacksonville, Florida
Clinical Site Partners, LLC Leesburg dba Flourish Research
Leesburg, Florida
Suncoast Research Group, LLC Miami - Little Havana dba Flourish Research
Miami, Florida
Well Pharma Medical Research Corporation
Miami, Florida
University of South Florida - PARENT
Tampa, Florida
Clinical Site Partners, LLC Orlando dba Flourish Research
Winter Park, Florida
Aeroallergy Research Laboratories of Savannah, Inc.
Savannah, Georgia
Duly Health and Care
Winfield, Illinois
Accellacare of McFarland Clinic
Ames, Iowa
The Iowa Clinic, PC
West Des Moines, Iowa
University of Kansas Medical Center
Kansas City, Kansas
Bluegrass Allergy Research
Lexington, Kentucky
Allergy & Asthma Specialists, PSC
Owensboro, Kentucky
Continental Clinical Solutions, LLC
Towson, Maryland
Infinity Medical Research Inc
Russells Mills, Massachusetts
Clinical Research Institute
Minneapolis, Minnesota
Mayo Clinic - Rochester
Rochester, Minnesota
The Curators of the University of Missouri on behalf of University of Missouri Health Care
Columbia, Missouri
Midwest Chest Consultants
Saint Charles, Missouri
Sundance Clinical Research
St Louis, Missouri
The Clinical Research Center, LLC
St Louis, Missouri
Montana Medical Research, Inc.
Missoula, Montana
Showing 40 of 106 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.